India’s pharmaceutical consulting ecosystem is scaling in line with the country’s expanding life sciences and healthcare manufacturing base. With the pharmaceutical market valued above USD 55 billion and expected to grow beyond USD 130 billion in the coming years, consulting demand is rising sharply across regulatory, clinical, and commercialization domains. Export-led growth, coupled with stronger global quality expectations, is pushing companies to rely more on specialized advisory support for compliance and international market access.
Business momentum is... >>More
Atul Suri, Senior Vice President & SBU Head, Alembic Pharmaceuticals
Jaideep Gogtay, Global Chief Medical Officer, Cipla
Rehan Khan, Managing Director, MSD India